Fludarabine, Cyclophosphamide, and Alemtuzumab (FCC) In Relapsed/Refractory Patients with B-Cell Chronic Lymphocytic Leukemia (CLL): Final Report of the Italian Study

Autor: Montillo, Marco, Tedeschi, Alessandra *, Ricci, Francesca *, Zaccaria, Alfonso *, Crugnola, Monica *, Spriano, Mauro *, Spedini, PierAngelo *, Ilariucci, Fiorella *, Uziel, Lilj *, Attolico, Immacolata *, De Blasio, Angelo *, Vismara, Eleonora *, Morra, Enrica, Petrizzi, Valeria Belsito *
Zdroj: In Blood 19 November 2010 116(21):1384-1384
Databáze: ScienceDirect